Cargando…
Effects of trans-(±)-kusunokinin on chemosensitive and chemoresistant ovarian cancer cells
Ovarian cancer ranks eighth in cancer incidence and mortality among women worldwide. Cisplatin-based chemotherapy is commonly used for patients with ovarian cancer. However, the clinical efficacy of cisplatin is limited due to the occurrence of adverse side effects and development of cancer chemores...
Autores principales: | Mad-Adam, Nadeeya, Rattanaburee, Thidarath, Tanawattanasuntorn, Tanotnon, Graidist, Potchanapond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721857/ https://www.ncbi.nlm.nih.gov/pubmed/34992691 http://dx.doi.org/10.3892/ol.2021.13177 |
Ejemplares similares
-
Trans-(±)-Kusunokinin Binding to AKR1B1 Inhibits Oxidative Stress and Proteins Involved in Migration in Aggressive Breast Cancer
por: Tanawattanasuntorn, Tanotnon, et al.
Publicado: (2022) -
Trans-(−)-Kusunokinin: A Potential Anticancer Lignan Compound against HER2 in Breast Cancer Cell Lines?
por: Rattanaburee, Thidarath, et al.
Publicado: (2021) -
Anticancer Activity of (±)-Kusunokinin Derivatives towards Cholangiocarcinoma Cells
por: Rattanaburee, Thidarath, et al.
Publicado: (2022) -
(−)-Kusunokinin as a Potential Aldose Reductase
Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation
por: Tanawattanasuntorn, Tanotnon, et al.
Publicado: (2020) -
Potential Stereoselective Binding of Trans-(±)-Kusunokinin and Cis-(±)-Kusunokinin Isomers to CSF1R
por: Chompunud Na Ayudhya, Chompunud, et al.
Publicado: (2022)